1[1]CIBIS- Ⅱ Investigators and Committees. The cardiac insufficiency bisoprolol study Ⅱ (CIBIS- Ⅱ ) a randomised trial[ J ].Lancet, 1999,353:9.
2[2]Hjalmarson F, Goldstein S. Effects of controlled - release metoprolol on total mortality, hospitalization, and well - being in patients with heart failure:The metoprolol CR/XL randomized international trial in congestive heart failure( MERIT- HF)[ J].JAMA, 2000,283:1 295.
3[3]Packer M, Fowler M, Rouleau J, et al. COPERNICUS (carvedilol prosective randomized cumulative survival trial):a multicenter randomized double- blind, placebo - controlled study to determine the effect of carvedilol onmortality in severe congestive heart failure[J] . Cardiovasc Drugs Ther, 1999,13:24.
4[4]The International Steering Committee on Behalt of the MERIT - HF Study Group. Rationale, design and organization of metoprolol CR/XL randomized intervention trial heart failure ( MERIT - HF) [ J ]. Am J Cardiol, 1997,80( Suppl 9B): 54J.
5[5]MERIT- HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure( MERIT - HF) [ J]. Lancet,1999,353:2 001.
6[6]The CIBIS Ⅱ Scientific Committee. Design of the cardiac insufficiency bisoprolol study Ⅱ ( CIBIS Ⅱ ) [ J ]. Fundam Clin Pharmacol, 1997,1 1: 138.
7[7]Simon T, Mary - Krause M, Funck - Brentano C, et al. Female gender is an independent predictor of survival in patient with chronic heart failure:results from the cardiac insufficiency bisoprolol study(CIBIS Ⅱ ) [J]. Circulation, 1999, 100(Suppl 1 ):1.
8[8]Mc Gowan J, Murphy R, Cleland JGF. Carvedilol for heart failure:clinical trial in progress[J]. Heart failure Rev, 1999,4:89.
9[9]Mikkelsen K, Barstad S, Skaland K, et al. Timolol - induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction[J] . N Engl J Med, 1981,304:801.
10[10]Olsson G, Rehnqvist N. Long- term with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity[J].J Am Coll Cardiol, 1985,5: 1 428.
